Concepedia

Publication | Closed Access

Real‐world efficacy and safety of sofosbuvir + ribavirin for hepatitis C genotype 2: A nationwide multicenter study by the Japanese Red Cross Liver Study Group

DOI

32

Citations

37

References

2018

Year

Takehiro Akahane, Masayuki Kurosaki, Jun Itakura, Keiji Tsuji, Kouji Joko, Hiroyuki Kimura, Akihiro Nasu, Chikara Ogawa, Yuji Kojima, Chitomi Hasebe,
Hepatology Research

Abstract

Treatment with SOF + RBV was highly effective and safe in Japanese patients with HCV genotype 2 infection.

References

YearCitations

Page 1